Cook Medical continues to offer new treatments for aortic diseases


Cook Medical has received FDA approval to market its improved Zenith AAA Iliac Flex Legs and has recently submitted an IDE application to the FDA for its Zenith Fenestrated Abdominal Aortic Aneurysm Endovascular Graft, which is the first of its kind to incorporate custom-tailored openings in the top section of the endograft. Cook Medical has also received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial for its Zenith Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft. The trial, which will include 24 sites, is designed to evaluate the safety and effectiveness of the smaller endograft delivery system in 120 patients, enabling the endovascular treatment of AAA patients with smaller vascular access vessels who otherwise may not have been candidates for minimally invasive endovascular treatment.